JP2022534302A5 - - Google Patents

Info

Publication number
JP2022534302A5
JP2022534302A5 JP2021570919A JP2021570919A JP2022534302A5 JP 2022534302 A5 JP2022534302 A5 JP 2022534302A5 JP 2021570919 A JP2021570919 A JP 2021570919A JP 2021570919 A JP2021570919 A JP 2021570919A JP 2022534302 A5 JP2022534302 A5 JP 2022534302A5
Authority
JP
Japan
Application number
JP2021570919A
Other languages
Japanese (ja)
Other versions
JPWO2020239999A5 (https=
JP7547387B2 (ja
JP2022534302A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/065024 external-priority patent/WO2020239999A1/en
Publication of JP2022534302A publication Critical patent/JP2022534302A/ja
Publication of JPWO2020239999A5 publication Critical patent/JPWO2020239999A5/ja
Publication of JP2022534302A5 publication Critical patent/JP2022534302A5/ja
Priority to JP2024146717A priority Critical patent/JP2024167319A/ja
Application granted granted Critical
Publication of JP7547387B2 publication Critical patent/JP7547387B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021570919A 2019-05-31 2020-05-29 NF-κB誘導キナーゼの低分子阻害剤 Active JP7547387B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024146717A JP2024167319A (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962855144P 2019-05-31 2019-05-31
US62/855,144 2019-05-31
US201962907833P 2019-09-30 2019-09-30
US62/907,833 2019-09-30
PCT/EP2020/065024 WO2020239999A1 (en) 2019-05-31 2020-05-29 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024146717A Division JP2024167319A (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Publications (4)

Publication Number Publication Date
JP2022534302A JP2022534302A (ja) 2022-07-28
JPWO2020239999A5 JPWO2020239999A5 (https=) 2023-06-05
JP2022534302A5 true JP2022534302A5 (https=) 2023-06-05
JP7547387B2 JP7547387B2 (ja) 2024-09-09

Family

ID=71108552

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021570919A Active JP7547387B2 (ja) 2019-05-31 2020-05-29 NF-κB誘導キナーゼの低分子阻害剤
JP2024146717A Pending JP2024167319A (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024146717A Pending JP2024167319A (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Country Status (37)

Country Link
US (3) US11254673B2 (https=)
EP (2) EP3976597B1 (https=)
JP (2) JP7547387B2 (https=)
KR (1) KR20220027871A (https=)
CN (2) CN114222737B (https=)
AU (1) AU2020282005B2 (https=)
BR (1) BR112021023796A2 (https=)
CL (1) CL2021003142A1 (https=)
CO (1) CO2021017838A2 (https=)
CR (1) CR20210587A (https=)
DK (1) DK3976597T3 (https=)
DO (1) DOP2021000244A (https=)
EC (1) ECSP21093623A (https=)
ES (1) ES2989387T3 (https=)
FI (1) FI3976597T3 (https=)
HR (1) HRP20241352T1 (https=)
HU (1) HUE068694T2 (https=)
IL (1) IL288387B2 (https=)
JO (1) JOP20210318B1 (https=)
LT (1) LT3976597T (https=)
MA (1) MA56038B1 (https=)
MD (1) MD3976597T2 (https=)
MX (1) MX2021014679A (https=)
MY (1) MY205653A (https=)
PE (1) PE20220768A1 (https=)
PH (1) PH12021553011A1 (https=)
PL (1) PL3976597T3 (https=)
PT (1) PT3976597T (https=)
RS (1) RS66105B1 (https=)
SA (1) SA521430960B1 (https=)
SG (1) SG11202112994WA (https=)
SI (1) SI3976597T1 (https=)
SM (1) SMT202400418T1 (https=)
TW (2) TWI850390B (https=)
UA (1) UA130430C2 (https=)
UY (1) UY38721A (https=)
WO (1) WO2020239999A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114222737B (zh) * 2019-05-31 2024-07-26 詹森药业有限公司 NF-κB诱导激酶的小分子抑制剂
WO2020243423A1 (en) 2019-05-31 2020-12-03 Ikena Oncology, Inc. Tead inhibitors and uses thereof
KR20220030222A (ko) 2019-05-31 2022-03-10 이케나 온콜로지, 인코포레이티드 Tead 억제제 및 이의 용도
IL316886A (en) * 2022-05-11 2025-01-01 Janssen Pharmaceutica Nv History of pyrrolidinones as NF kappa B kinase inhibitors
CA3257152A1 (en) * 2022-05-11 2023-11-16 Janssen Pharmaceutica Nv Pyrrolidine derivatives useful as NF-κB induction kinase inhibitors
EP4637773A1 (en) 2022-12-22 2025-10-29 Boehringer Ingelheim International GmbH Crystalline forms of a her2 inhibitor
WO2025020886A1 (zh) * 2023-07-27 2025-01-30 浙江星浩澎博医药有限公司 氮杂喹唑啉环衍生物及其用途
IL326016A (en) 2023-07-28 2026-03-01 Boehringer Ingelheim Int Process for manufacturing a HER2 inhibitor
WO2025235874A1 (en) * 2024-05-10 2025-11-13 Schrödinger, Inc. Heterocyclics as egfr inhibitors
JP2026022634A (ja) * 2024-07-30 2026-02-12 日本たばこ産業株式会社 ピラゾロピリミジン化合物及びその医薬用途

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9930616D0 (en) 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
US7132428B2 (en) 2003-07-03 2006-11-07 Aventis Pharmaceuticals Inc. Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
JP2008509138A (ja) * 2004-08-03 2008-03-27 ワイス 心臓血管疾患の治療に有用なインダゾール類
WO2006053277A2 (en) 2004-11-12 2006-05-18 Chippac, Inc. Wire bond interconnection
AU2009263037B2 (en) * 2008-06-26 2011-10-06 Amgen Inc. Alkynyl alcohols as kinase inhibitors
WO2010042337A1 (en) 2008-10-07 2010-04-15 Merck Sharp & Dohme Corp. Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
MX2013010513A (es) * 2011-03-16 2013-10-07 Hoffmann La Roche Compuestos de alcohol 6,5-heterociclil-propargilico y usos de los mismos.
JP2015507001A (ja) 2012-02-17 2015-03-05 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 三環式化合物及びその使用方法
US8859553B2 (en) * 2012-07-30 2014-10-14 Astar Biotech Llc Protein kinase inhibitors
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
US20150057260A1 (en) * 2013-08-22 2015-02-26 Genentech, Inc. Alkynyl alcohols and methods of use
US20160096850A9 (en) * 2013-08-22 2016-04-07 Genentech, Inc. Alkynyl alcohols and methods of use
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
AU2015334917B2 (en) 2014-10-23 2019-08-29 Janssen Pharmaceutica Nv New compounds as NIK inhibitors
BR112017008039B1 (pt) 2014-10-23 2023-04-11 Janssen Pharmaceutica N.V. Derivados de pirazol como inibidores de nik, seu uso no tratamento ou prevenção de câncer e composição farmacêutica que os compreende
JP6616412B2 (ja) 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ.ベー. Nik阻害剤としての新規のピラゾロピリミジン誘導体
MX371151B (es) 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv NUEVOS DERIVADOS DE TIENOPIRIMIDINA EN CALIDAD DE INHIBIDORES DE LA CINASA INDUCTORA DE NF-kB (NIK).
JP2018510140A (ja) 2015-02-25 2018-04-12 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft アルキニルアルコール及び使用方法
ES2775449T3 (es) 2016-01-22 2020-07-27 Janssen Pharmaceutica Nv Nuevos derivados de cianoindolina sustituida como inhibidores de nik
EP3405464B1 (en) 2016-01-22 2019-12-04 Janssen Pharmaceutica NV New 6-membered heteroaromatic substituted cyanoindoline derivatives as nik inhibitors
ES2837157T3 (es) 2016-06-30 2021-06-29 Janssen Pharmaceutica Nv Derivados de cianoindolina como inhibidores de NIK
WO2018002217A1 (en) 2016-06-30 2018-01-04 Janssen Pharmaceutica Nv Heteroaromatic derivatives as nik inhibitors
WO2018037058A1 (en) * 2016-08-24 2018-03-01 F. Hoffmann-La Roche Ag 2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use
WO2018037059A1 (en) 2016-08-24 2018-03-01 F. Hoffmann-La Roche Ag 2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use
CN110831940B (zh) 2017-07-06 2023-06-20 詹森药业有限公司 作为nik抑制剂的新取代的氮杂吲哚啉衍生物
CN109810110B (zh) * 2017-11-22 2023-01-24 中国科学院上海药物研究所 一种具有2-氨基嘧啶结构的化合物,其制备方法和用途
CN114222737B (zh) * 2019-05-31 2024-07-26 詹森药业有限公司 NF-κB诱导激酶的小分子抑制剂
WO2020243423A1 (en) 2019-05-31 2020-12-03 Ikena Oncology, Inc. Tead inhibitors and uses thereof
CR20240234A (es) 2019-05-31 2024-07-09 Sage Therapeutics Inc ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629)
KR20220030222A (ko) 2019-05-31 2022-03-10 이케나 온콜로지, 인코포레이티드 Tead 억제제 및 이의 용도
BR112021022099A2 (pt) 2019-05-31 2021-12-28 Chiesi Farm Spa Derivados de amino quinazolina como inibidores de p2x3
WO2021067217A1 (en) 2019-09-30 2021-04-08 Incyte Corporation Pyrido[3,2-d]pyrimidine compounds as immunomodulators

Similar Documents

Publication Publication Date Title
JP2022534302A5 (https=)
CN305981863S (https=)
CN305837529S (https=)
CN305832889S (https=)
CN305831517S (https=)
CN305830841S (https=)
CN305786545S (https=)
CN305785253S (https=)
CN305784630S (https=)
CN305782749S (https=)
CN305537146S (https=)
CN305537000S (https=)
CN305981341S (https=)
CN305779420S (https=)
CN305534878S (https=)
CN305534657S (https=)
CN305534243S (https=)
CN305533975S (https=)
CN305779012S (https=)
CN305533140S (https=)
CN305532887S (https=)
CN305778063S (https=)
CN305768502S (https=)
CN305531306S (https=)
CN305531184S (https=)